FDA SAFETY SURVEILLANCE OF COVID-19 VACCINES :
DRAFT WORKING LIST OF POSSIBLE ADVERSE EVENT OUTCOMES
SUBJECT TO CHANGE

 Guillain-Barré syndrome
 Acute disseminated encephalomyelitis
 Transverse myelitis
 Encephalitis/myelitis/encephalomyelitis/ meningoencephalitis/meningitis/encepholapathy
 Convulsions/seizures
 Stroke
Narcolepsy and cataplexy
Anaphylaxis
Acute myocardial infarction
 Myocarditis/pericarditis
Autoimmune disease
Deaths
Pregnancy and birth outcomes
Other acute demyelinating diseases
Non-anaphylactic allergic reactions
Thrombocytopenia

Disseminated intravascular coagulation
Venous thromboembolism
Arthritis and arthralgia/joint pain
Kawasaki disease

Multisystem Inflammatory Syndrome in Children
Vaccine enhanced disease

READ THE REST:

VERY INTERESTING LISTS #VIL 2: FDA EXPECTS THESE ADVERSE REACTIONS TO COVID JABS. SINCE OCTOBER 2020

Add New Post

SavedPreview(opens in a new tab)Add titleFDA SAFETY SURVEILLANCE OF COVID-19 VACCINES : DRAFT Working list of possible adverse event outcomes – October 22, 2020 – *****THEY KNEW*****